EVENTS
BRANO

The 14th Branislav “Brano”
Radovancevic International
Heart Failure Forum

Innovations and
New Treatment Strategies
in Heart Failure

September 6th – 8 th, 2022
Savoia Excelsior Palace
Trieste / Italy

  • Greeteings
    Ugolino Livi, University Hospital, Udine, Italy
null
  • Start-Up of a Perfusion Education Program
    Eric Solberg, Houston, USA
null
  • ECMO in Primary Graft Dysfunction – How Long?
    Ruzica Mrkonjic, Zagreb, CRO
null
  • GDP (Goal-Directed Perfusion) strategy in ECC:
    Advantages and Opportunities
    Marco Ranucci, Milan, IT
null
  • ECMO in COVID 19: Neurological Outcomes
    Lisa Janowiak, Houston, USA
null
  • Advances in HF Treatments: Education for Staff
    Marie Clark, Houston, USA
null
  • Organizing Mechanical Circulatory Support:
    Personnel Requirements
    Saso Klesnik, Houston, USA
null
  • ECMO in Primary Graft Dysfunction – How Long?
    Ruzica Mrkonjic, Zagreb, CRO
null
  • Reducing gaseous microemboli
    Kulic Slavko
null
  • ECMO in COVID 19: Neurological Outcomes
    Lisa Janowiak, Houston, USA
null
  • First Line LV venting option: IABP or IMPELLA
    or Apical Drainage
    Cristiano Amarelli, Napoli, IT
null
  • Technical Issues in Transmedics Organ Preservation
    Andrea Lechiancole, Udine, IT
null
  • The Role of Purification in Organ Transplantation
    Massimo Boffini, Turin, IT
null
  • Pulsatile ECMO: a new Generation of Cardiac Assistance
    Paolo Meani, Milan, IT
null
  • End-stage Heart Failure: 50 years of Promises
    and Accomplishments
    O.H. Frazier, Houston, USA
null
  • Effect of SARS-Cov-2 on Cardiovascular System
    Marco Merlo, Trieste, IT
null
  • Update on Heart Failure Pharmacology Therapies
    Paul Mohacsi, Bern, SWI
null
  • Allocation of Hospital Resources in COVID-19 Pandemic
    Bindu Akkanti, Houston, USA
null
  • Update on Cardiac Resynchronisation Therapy
    A. Kosztin
null
  • Temporary MCS: “Escalation and De-Escalation Strategies
    Aly El-Banayosy, Oklahoma City, USA
null
  • ECMO and HEMOLUNG in COVID 19
    Kha Dinh, Houston, USA
null
  • ECMELLA 2.0
    Angelo Nascimbene, Houston, USA
null
  • Cardiogenic Shock and Temporary Circulatory Support
    Bart Meyns, Leuven, BEL
null
  • Surgical Technique of Ecmella 2.0 and 2.1
    Evgenij Potapov, Berlin, GER
null
  • Five-Year Momentum Outcome Data with the HeartMate3
    Nir Uriel, New York, USA
null
  • Perioperative Management and Neurological Complications
    after LVAD Implant
    James Long, Oklahoma City, USA
null
  • How to Avoid LVAD Patients Visiting an Emergency Department?
    Martin Strueber, Memphis, USA
null
  • 3D Planing for LVADs: Chest Fitting, LIS Surgical Approach,
    Outflow Graft Positioning
    Istvan Hartyanszky, Budapest, HUN
null
  • Impact of Worsening Aortic Regurgitation on Outcomes
    in 396 LVAD Recipients
    Hrvoje Gasparovic, Zagreb, CRO
null
  • Pulsatile Versus Non-pulsatile Blood Flow
    Walter Dembitsky, San Diego, USA
null
  • CH-VAD
    Frank Lin, Torrance, USA
null
  • FineHeart
    Francis Pagani, Ann Arbor, USA
null
  • TORVAD
    Richard W. Smalling, Houston, USA
null
  • Total Heart Replacement
    O.H. Frazier, Houston, USA
null